Steady-state levels of HIV-1 viraemia in the plasma vary more than a 1000-fold between HIV-positive patients and are thought to be in£uenced by several di¡erent host and viral factors such as host target cell availability, host anti-HIV immune response and the virulence of the virus. Previous mathematical models have taken the form of classical ecological food-chain models and are unable to account for this multifactorial nature of the disease. These models suggest that the steady-state viral load (i.e. the setpoint) is determined by immune response parameters only. We have devised a generalized consensus model in which the conventional parameters are replaced by so-called`process functions'. This very general approach yields results that are insensitive to the precise form of the mathematical model. Here we applied the approach to HIV-1 infections by estimating the steady-state values of several process functions from published patient data. Importantly, these estimates are generic because they are independent of the precise form of the underlying processes. We recorded the variation in the estimated steady-state values of the process functions in a group of HIV-1 patients. We developed a novel model by providing explicit expressions for the process functions having the highest patient-to-patient variation in their estimated values. Small variations from patient to patient for several parameters of the new model collectively accounted for the large variations observed in the steady-state viral burden. The novel model remains in full agreement with previous models and data.
INTRODUCTION
HIV-1 infection is characterized by high levels of virus in both the plasma and lymph nodes of infected individuals during all stages of the disease (Embretson et al. 1993; Pantaleo et al. 1993; Piatak et al. 1993) . After an initial peak of viraemia in primary infection, virus levels stabilize around a certain set-point and typically increase only slowly thereafter (Weiss 1993; Mellors et al. 1996) . The viral load is a steady-state balance between ongoing extensive virus replication and rapid clearance (Ho et al. 1995; Wei et al. 1995; Perelson et al. 1996) . The level of this steady state, as re£ected by the virus titre in peripheral blood, shows enormous variation from patient to patient. Even after discarding the highest measurements, the variation remains over 1000-fold (Piatak et al. 1993) . Moreover, the set-point is strongly correlated with the rate of progression (Mellors et al. 1996) . The steady-state viral burden is in£uenced by several di¡erent host and viral factors including target cell availability Orendi et al. 1998) , the humoral immune response (Fauci 1993) , the cellular immune response (Borrow et al. 1994; Rinaldo et al. 1995; Borrow et al. 1997; Goulder et al. 1997; Ogg et al. 1998; Jin et al. 1999; Schmitz et al. 1999 ) and virulence factors (Deacon et al. 1995; Katzenstein et al. 1996) .
Mathematical models of HIV-1 infection typically have the form of an ecological food-chain model, with target cells as the prey, productively infected cells as their predator and the immune response as the top predator (Nowak & Bangham 1996; . A major problem with such models in both ecology (Arditi & Ginzburg 1989; Ginzburg & Akc°akaya 1992; Abrams 1994; Kaunzinger & Morin 1998) and virology ) is the strong dependence of steady-state results on the precise form and length of the food chain. For instance, in a typical cytotoxic T-cell model, large variations in the HIV-1 burden require a similar variation in a parameter called the`immune responsiveness' (Nowak & Bangham 1996) . However, such a variation, which spans several orders of magnitude, is not easily accounted for by a single biological attribute. Rather, it is expected that several factors contribute to the variation. Indeed, the experimental evidence cited above suggests that several factors besides immune responsiveness play a role.
Complications like this are typical of mathematical food-chain models. A famous example from ecology is thè paradox of enrichment' (Rosenzweig 1971) , where increasing the food availability of a prey population fails to increase the steady-state level of that population. Rather, it is the next level of the food chain, i.e. the predator, that pro¢ts from the enrichment by an increase in its steady-state level. Conversely, in a three-dimensional food chain consisting of a prey, a predator and a top predator population, only the prey and the top predator ultimately bene¢t from an enrichment of the food availability of the prey. Generally, the correlations between the steady states of the di¡erent populations in food-chain models are determined by (i) the number of populations in the food chain, (ii) saturation e¡ects within the di¡erent populations, and (iii) competition e¡ects within the di¡erent populations (Arditi & Ginzburg 1989; Ginzburg & Akc°akaya 1992; Abrams 1994; Kaunzinger & Morin 1998 ). Whether or not mathematical models are in agreement with, for example, the observed negative correlation between the speci¢c CD8 + T-cell immune response and the viral load (Ogg et al. 1998) or with the positive correlation between the viral load and target cell levels (Orendi et al. 1998) does not rest on a generic property of the models. Instead, it depends on the length of the food chain of the model and/or on the precise form of the interaction terms.
Developing mathematical models for HIV-1 infection that are simple enough to allow a good understanding and realistic enough to allow small variations in several factors to account collectively for large variations in the viral burden during the asymptomatic quasi-steady state remains a major challenge. The main objective of this paper is to pick up this challenge by developing a novel heuristic approach that allows the identi¢cation of the processes controlling the steady-state levels. The approach is applied here to a discussion of the factors controlling HIV-1 during clinical latency.
A CONSENSUS MODEL WITH`PROCESS FUNCTIONS'
We adopt a widely used minimal model of an HIV-1 infection (Nowak & Bangham 1996; Bonhoe¡er et al. 1997a,b; written in theÀrden notation' (http://www-binf.bio.uu.nl/$rdb/arden.html). The model considers target cells T, productively infected cells I, virus V and immune e¡ector CD8 + T cells E. The structure of the model resembles an ecological food chain of a prey T, its predator I with a life stage V and a top predator E (De Boer & Perelson 1998). Since the steadystate levels during HIV-1 clinical latency are changing on a very slow time-scale of years, one typically studies the equilibria of the model. The novelty of our approach resides in the interpretation of the parameters of the model: any`parameter' in equations (1)^(4) is explicitly allowed to be any function of the other`parameters' and/ or variables of the model. Because each`parameter' in fact re£ects a process, we call each of them a`process function'. For example, the process by which target cells are produced could be written as aQ , where aQ represents the activation a of quiescent cells Q (Stilianakis et al. 1997) ; the process of the activation of the immune response could be written as a saturation function a/(h I) ) and the death process of infected cells could be made dependent on the immune response kE, where k is the killing rate. This interpretation of parameters as processes allows us to postpone the speci¢cation of the interaction between the immune response E and equations (1)^(4). Thus, we ¢rst obtain generic results that are truly independent of the form of this interaction.
We write our generalized consensus model as follows:
where the process function is the source of target cells, is an infection process, f is the fraction of successful infections, p represents the rate of virion production, c is the virion clearance rate and is the immune responsiveness. All process functions determine death rates. One can easily see that this comprises a three-dimensional food chain because the fast time-scale of equation (3) typically allows for its replacement by the quasi-steadystate assumption V ( p/c)I.
One obtains the steady-state expressionŝ
and
from equations (4), (3) and (1), respectively. Equation (5) suggests that the only factors determining the steady-state level of productively infected cellsÎ are the`immune responsiveness' and the death rate of immune e¡ectors E (Nowak & Bangham 1996) . Because one expects E to vary little between patients, large variations inÎ would require similar variations in . Other factors such as target cell availability and viral virulence seem to have no e¡ect whatsoever in controllingÎ because they are not re£ected in either E or . This is a generalization of an earlier study (Nowak & Bangham 1996) because we have not speci¢ed the e¡ect of the immune response on the system beforehand. Formally, it is not known whether patients di¡ering by orders of magnitude in their viral load in the peripheral blood (Mellors et al. 1996) also have large di¡erences in the total body counts of productively infected cellsÎ. From equation (6), di¡erences in the viral production p and in the viral clearance c could contribute to the observed variations inV. However, there is little indication that patients di¡er markedly in p (Haase et al. 1996; Hockett et al. 1999) or in c (Perelson et al. 1996; Mittler et al. 1999; Ramratnam et al. 1999) . Moreover, there is good correlation between the numbers of productively infected cells and the amounts of virus in the lymphoid tissue or in the peripheral blood (Hockett et al. 1999) . Finally, the fact that the viral burden in the peripheral blood is a good predictor of the rate of disease progression (Mellors et al. 1996) also suggests that patients with a high viral load do have a severe infection, i.e. do have a highÎ. In this paper we therefore wish to explain large di¡erences inÎ with small di¡erences in parameter values. Equation (5) fails to account for this: large di¡er-ences inÎ require large di¡erences in .
Because there is no explicit connection between equation (4) and the rest of the system, we cannot determine the steady stateÊ. However, for the special case whereÊ 0 or whereÊ is at a constant (e.g. maximum) level, one can drop equation (4) from the system and obtain a target-cell-limited solution (McLean et al. 1991; McLean & Nowak 1992; ) from equations (2), (1) and (3), respectively, i.e.
These steady-state expressions di¡er radically from the expressions in equations (5)^(7). This illustrates the problem outlined in ½ 1, i.e. that steady states in a foodchain model depend crucially on its form and length (Arditi & Ginzburg 1989; Ginzburg & Akc°akaya 1992; Abrams 1994; Kaunzinger & Morin 1998) .
PUBLISHED ESTIMATED VALUES
Several steady-state values of the process functions and the variables of this consensus model have been estimated previously. For the turnover of productively infected cells we use the consensus estimate of 9 0:5/d (Ho et al. 1995; Wei et al. 1995; Klenerman et al. 1996; Perelson et al. 1996; Notermans et al. 1998) . Between patients there is remarkably little variation in . Recent plasmapheresis experiments have provided novel estimates of 40^110 min for the half-life of HIV virions Ramratnam et al. 1999 ). An intermediate value is therefore 75 min, i.e. c 13/d, but little is known about the patient-to-patient variation in c. Estimates for the production rate p vary between a few hundred (Haase et al. 1996 ) and a few thousand (Hockett et al. 1999) . The latter study suggested that there is little variation in p between patients di¡ering markedly in their viral burden (Hockett et al. 1999) . The death rate of HIV-1-speci¢c CD8+ e¡ector cells during anti-retroviral therapy has been estimated by a tetramer assay as E 0:015/d (Ogg et al. 1999) . Most of the virus is trapped on the surface of follicular dendritic cells (FDCs) (Pantaleo et al. 1993; Hockett et al. 1999) , with an average pool size of order of magnitude 10 10 particles in the lymphoid tissue (Cavert et al. 1997) . In di¡erent studies addressing the lymphoid tissue, the total body counts of productively infected cells have varied between 10 7 (Chun et al. 1997 ) and 10 8 (Cavert et al. 1997 ).
We will assume here that dividing CD4 + T cells form the main pool of target cells. Since, for human CD4 + T cells, cell division takes approximately a day (Fleury et al. 1998) , we assume that T 9 1/d. Identifying dividing CD4 + T cells in the lymphoid tissue with the Ki67 monoclonal antibody yields estimates varying around 10 9 target cells (Fleury et al. 1998; Zhang et al. 1998) . In addition, labelling studies with 2 H-glucose have suggested that the percentage of dividing CD4 + T cells is 1% in healthy controls and 3^5% in HIV-1 patients (Hellerstein et al. 1999) . Having approximately 2:5 Â 10 11 CD4 + T cells this also suggests a total body count of approximately 10 9 target cells.
(a) Estimating values of process functions
The approach developed here is an attempt to breach the non-robustness of results obtained by solving for steady-state levels in food-chain models. In order to obtain generic results a`consensus' model that is a generalization of many di¡erent more detailed models having di¡erent explicit expressions for the di¡erent process functions is required. The model in equations (1) 
and rewriting equation (4) gives
The steady state of equation (2) gives fÎ VT c fpT ,
and, hence, from equation (1) we obtain that TT fÎ .
( 1 4 ) Note again that these expressions are obtained for any form of immune control in the consensus model, i.e. they are obtained without specifying the interaction between the immune e¡ectors E and the remainder of the system. In order to illustrate basic principles, we estimate the values of process functions from previously published data on approximately ten HIV-1-infected asymptomatic patients. The data in table 1 compile estimates from three di¡erent papers providing (i)Î andV, i.e. the number of productively infected cells and virions trapped on FDCs in lymphoid tissue (Cavert et al. 1997) , (ii)T, i.e. the number of dividing CD4+ T cells in lymphoid tissue (Zhang et al. 1998) , and (iii) , i.e. the death rates of productively infected cells (Notermans et al. 1998) . KnowingÎ andV we can estimate p/c from equation (11). Since there is no information on the value of f , we calculate f from equation (13). Not knowing f we are not yet Large di¡erences explained by small variations V. Mu« ller and others 237 able to use equation (14) in estimating . As noted above, the estimates listed in table 1 re£ect true`values' of the corresponding process in that patient. The variation in these estimates therefore provides generic information about the variation in the processes determining the viral load in each patient. As a measure of the variation in each column, the bottom row of table 1 shows the ratio of the highest over the lowest value of each variable or process. The ¢rst line of table 1 gives a`typical patient', corresponding to a rounded average of the data.
The variation in this data set seems considerably less than the typical orders of magnitude variation (Mellors et al. 1996) . The variations inV andÎ are`only' 17-fold and 24-fold, respectively (see table 1 ). This is partly due to the fact that we considered the lymphoid tissue. In peripheral blood the variation in the viral load is approximately 100-fold (Notermans et al. 1998). However, in this patient set, the viral load in the peripheral blood is not correlated with eitherV orÎ in the lymphoid tissue. Because the total body viral load is largely con¢ned to the lymphoid tissue, here we only consider lymphoid tissue data. We will return to the issue of explaining the orders of magnitude variation in ¢gure 1.
Although we found a reasonable correlation betweenÎ andV (r 0:79 and p50:01) in this study, the 8.5-fold variation in p/c demonstrates that there is still considerable variation in theV /Î ratio. Note that there is a discrepancy with the study of Hockett et al. (1999) who foundV /Î ratios that were an order of magnitude larger. This is probably due to di¡erent measurement techniques. In the data sets used for the present paper and with the intermediate estimate of c 13/d Ramratnam et al. 1999) we obtained production rates p of a few thousand virions per cell per day. The observed 8.5-fold variation could obviously be due to patient di¡er-ences in c, p or in the retention of virus particles in the lymphoid tissue. Finally, the two process functions that vary most are and f .
EXPLICIT EXPRESSIONS FOR PROCESS FUNCTIONS (a) The cytotoxic model
One can retrieve previous cytotoxic control models by allowing the process to depend on the immune response. For example, one could write
or
where I is the normal death rate and kE represents the cytotoxic killing of productively infected cells. In the model of Nowak & Bangham (1996) the killing is weighted by the immune responsiveness , as in equation (15). Using equations (11)^(14) and setting f 1, one can again calculate , p/c, and for every patient in table 1 in order to obtain the correct steady state with either of these models. The novel parameters I and k only change the steady-state immune responseÊ and no other variable of the system. They can be changed freely provided that I 5 andÊ40.
Having speci¢ed the e¡ect of the immune response in equations (15) and (16) (Cavert et al. 1997) , this should provide a fair estimate of the total body burden. The number of target cellsT was calculated from table 2 in Zhang et al. (1998) (15) it is a non-monotonic function of the immune responsiveness (Nowak & Bangham 1996) and with equation (16) it is an increasing saturation function of . Moreover, one may study models that are totally independent of target cell levels by letting f 1/T. In such modelsÊ is either independent of (with equation (16)) or an inverse function of (with equation (15)). Thus, these four cytotoxic models all have di¡erent predictions for the relation between the steady-state immune responsê E and and, hence (see equations (5) and (6)), for the relation betweenÊ and the viral loadV. Having such nongeneric predictions it seems impossible to conclude whether or not cytotoxic control models are in agreement with the observed strong negative correlation between the viral burdenV and the cytotoxic immune responseÊ as reported by Ogg et al. (1998) . Finally, in all of these models, the large variation in the viral burden can only be attributed to large variations in the immune responsiveness (and, more unlikely, in the turnover of the immune response E ) (see equation (5) and Nowak & Bangham (1996) ). We have argued above that such large variations in are likely to involve a number of hidden factors.
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(b) Employing the variation in the estimated values
An important point of this paper is using the di¡er-ences in the patient-to-patient variation in the various process functions in order to incorporate more biology into the model. First, both and f are process functions that vary widely. If the number of productively infected cells I generally varies by orders of magnitude between patients (Mellors et al. 1996) , would also have to vary by orders of magnitude (Nowak & Bangham 1996) . To us this suggests that is not a`true' parameter and is, indeed, more likely to re£ect a process. Second, there is generally little variation between HIV-1-positive patients in the turnover of productively infected cells (Ho et al. 1995; Wei et al. 1995; Klenerman et al. 1996; Perelson et al. 1996) . By our process function approach this would suggest that can be explicitly expressed as a constant and that the cytotoxic expressions written above need not be the most appropriate choice for the e¡ect of the immune response. An alternative possibility is that most of the infected cells are removed by cytotoxic T lymphocytes (CTLs) before they start to produce virus in large quantities (Klenerman et al. 1996) . Since this can be incorporated by writing the process function f as an (1)^ (4), (17) and (18). The stable non-trivial equilibrium value I was calculated for 250 di¡erent parameter combinations of e, and and plotted against (a^c) the parameter values used, (d) the corresponding equilibrium value E, (e) the cytotoxicity level f , and ( f ) the potential`target-cell-limited' level I T in the case of an anti-CD8 treatment. The values of e, and were independently drawn from log-normal distributions, with a standard deviation such that 95% of the parameter values cover a threefold range around the estimated parameter values of the`typical patient' (see table 1 ). All other parameters are as described in the legend to table 1. The parameter estimates and equilibrium values of the typical patient are indicated by the horizontal and vertical lines. (d ) The dashed line indicates the Ogg et al. (1999) relationship. It is this ¢gure that sets our estimate of E 0 : by setting E 0 8 inÊ E 0 À 0:8 log I, we allow the rightmost patients (havingÎ 10 9 ) to still have an immune response ofÊ 0:8%. At I 10 10 the immune response vanishes.
explicit expression involving the immune response E, this would allow another process to account for part of the variation in f . Because of the data supporting a role of target cell availability and viral virulence in setting the steady-state viral burden,Î should not only depend on the immune responsiveness , but should also depend on the target cell production and the infection rate . In the consensus model this is not the case because the form of equation (4) only allows for solving the steady stateÎ from the immune response equation. Replacing by an expression allowing the proliferation of E to be a competitive saturation function of I (De Boer & Perelson 1998) allows one to tune parameters such that the steady state of equation (4) largely determinesÎ (i.e. for e 3 0) orÊ (i.e. for h 3 0). These biological constraints can be implemented in the consensus model by writing the following expressions for our process functions:
which allows for saturation in I and competition between the E cells, and the cytotoxic response eliminates a fraction of the recently infected cells. Note that now remains independent of E. Equations (17) and (18) represent an`early cytotoxicity' functional realization of the consensus model of equations (1)^(4). The cytotoxic killing of infected cells predominantly takes place in the earlier stages of cellular infection before the infected cells start to produce virus in large quantities (Klenerman et al. 1996) .
Setting proper values of the parameters of this model will yield the observed steady state. Thus, we can allow for more biology by imposing additional biological constraints on the values of e, and . The paper by Ogg et al. (1998) established a well-de¢ned inverse relation between the steady-state viral load and the CD8 + T-cell response in the peripheral blood. From ¢g. 2B in Ogg et al. (1998) we read that logRNA plasma 9 logRNA 0 À 2Ê, whereÊ is the CTL response measured as the percentage of CTLs speci¢c for HIV-1 epitopes. The paper by Hockett et al. (1999) allows us to compute the plasma RNA viral load from the number of productively infected cells in the tissue (i.e. I in the model) by their relationship logRNA plasma 9 logRNA 0 1:6 logÎ. In combination, this yields the result that the expected immune response isÊ 9 E 0 À 0:8 logÎ. For our typical patient this gives E 9 1:6% as a typical value (see table 1 ). In addition, experiments with SIV-infected macaques where anti-CD8 treatment resulted in an enormous increase in the viral burden (Jin et al. 1999; Schmitz et al. 1999) have suggested that the CD8 immune response has a large impact on the steady-state viral burden. Setting k 10 we achieve a removal of more than 95% of the infected cells (see the f -values in table 1). Thus, a rapid increase in the viral load is expected if one were to decrease E in order to simulate an anti-CD8 treatment (see below).
Having estimatedÊ fromÎ, we calculate the expected value of f from equation (18) . Knowing the expectedf , we are able to compute and from equations (13) and (14). Because we know that CD8 + e¡ector T cells can proliferate relatively fast, i.e. a 9 1 day À1 and because we think that, due to the high antigen load, the immune response to HIV should typically be saturated, i.e. h 10 6 (Î, we solve the competition parameter e from equations (12) and (17) (Mori et al. 2000; Oxenius et al. 2000) . Because eÊ ) 1 and h (Î, the EI proliferation term in equation (4) is approaching the`source' term E a/e. Apparently, we need only small variations in this source term.
The large variation in f has been resolved by small variations in f , but the variation in has remained large. The reason for this is that, if patients have a highV /Î ratio, then one obtains a high estimate for their scaled production rate p/c from equation (11). Hence, to account for their relatively lowÎ, a low estimate for is obtained from equation (13). The large residual variation in might be partly explained by di¡erent rates of retention in the lymphoid tissue, provided that free and bound virus particles have di¡erent infectivity.
The steady state turned out to be stable for all parameter values used in table 1 (and in ¢gure 1). Although we have concentrated on a steady-state analysis, we did check how our`typical patient' would respond to an anti-CD8 treatment (Jin et al. 1999; Schmitz et al. 1999) simulated by a large reduction of the e¡ector population (e.g. E Ê/100). Decreasing E this much sharply increases f such that the viral load increases more than tenfold in a few days. The target cells decrease on a similarly rapid time-scale and a target-cell-limited steady state is monotonically approached. However, thanks to the high proliferation rate of a 1 day
À1
, the e¡ector population recovers on a time-scale of weeks. As a consequence, the viral load decreases and target cells recover and the pre-treatment equilibrium in table 1 is approached monotonically on a time-scale of weeks (not shown). This is in good agreement with other data (Jin et al. 1999; Schmitz et al. 1999) .
In order to demonstrate that small parameter variations in this model can also account for the typically 1000-fold variations in the viral burden, we vary the values of e, and around their typical value in ¢gure 1. Taking the typical value for each parameter from table 1 as the mean of a log-normal distribution we set the standard deviation such that 95% of the parameter values cover at most a threefold range around the mean. Having drawn e, and independently, we compute the corresponding steady state of the system. We have plotted each actual parameter value with its corresponding steady stateÎ in ¢gure 1a^c. Allowing for this threefold variation in e, and only, we obtain a variation of three orders of magnitude inÎ. The immune responseÊ and cytotoxicity level f as they are realized by these parameter values are plotted in ¢gure 1d,e. Figure 1f depicts the expected e¡ect of the anti-CD8 treatment of Jin et al. (1999) and Schmitz et al. (1999) . The steady-state viral burden expected in the absence of an immune response, i.e.Î as de¢ned by equation (9), is plotted on the y-axis. Note that, over the entire range, this`target-cell-limited' I T level remains much higher than the`immunecontrolled'Î.
Our results demonstrate that, by the process function approach, we have indeed achieved what we aimed for. Variations in the viral burden are now collectively accounted for by variations in (i) the target cell production , (ii) the CD8 competition e, and (iii) the infection rate . Moreover, in order to account for the three orders of magnitude increase in the viral burden we only need a threefold variation in , and e. This seems a natural result because, by our present approach, processes varying widely are replaced by explicit expressions in terms of the dependent variables of the model and of new parameters. It thus becomes possible to account for the wide variation by combining smaller variations in several parameters and/or variables of the new model.
CONCLUSIONS
Obviously, our estimated values of the process functions remain crude approximations. For instance, it is probably not correct to assume that all Ki67 + CD4 + T cells are proper target cells for HIV-1. However, the estimates presented here mainly serve as an illustration of the process function approach that can be employed as a heuristic way of allowing experimental data to guide further model development. The parameter that retains most variation is the infection rate . Indeed, could be written as a function of the viral load V in order to re£ect the di¡erential trapping on the FDC network (Hockett et al. 1999) .
Empirical studies into the factors controlling an HIV-1 infection during clinical latency have largely relied on correlating the steady-state viraemia with steady levels of the immune response (Ogg et al. 1998 ) and/or with target cell availability (Orendi et al. 1998) . However, such an approach is not robust because di¡erent models predict radically di¡erent correlations. The inverse problem of estimating the values of processes from observed steadystate values gives far more robust results. In addition, the observed variations in these estimates suggested writing explicit expressions for the underlying process. This enabled us to develop novel models in which several factors collectively determine the steady-state viral burden in the asymptomatic phase.
